Phase I study of PF-04554878, a second-generation focal adhesion kinase (FAK) inhibitor, in patients with advanced solid tumors

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: 060fc76f85eda1ebaa9a8f05edec7dfa784c624d
First added on: Feb 04, 2025